WDR89 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 5.4754001332924E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.15439999995404E-06 |
Normal-vs-Stage2 |
1.784300E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.184360E-02 |
Stage1-vs-Stage2 |
3.322600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
1.395190E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.008200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.56249999605507E-08 |
Normal-vs-AfricanAmerican |
2.707600E-01 |
Normal-vs-Asian |
7.383800E-02 |
Caucasian-vs-AfricanAmerican |
9.350400E-01 |
Caucasian-vs-Asian |
2.400800E-01 |
AfricanAmerican-vs-Asian |
5.206600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.92310000002305E-06 |
Normal-vs-Female |
1.77244999999271E-05 |
Male-vs-Female |
9.933800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.270070E-02 |
Normal-vs-Extreme_Weight |
1.85591999999346E-05 |
Normal-vs-Obese |
1.023820E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.848400E-01 |
Normal_Weight-vs-Obese |
1.895010E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.709800E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.798600E-01 |
Normal-vs-Age(41-60Yrs) |
2.104100E-03 |
Normal-vs-Age(61-80Yrs) |
1.40709999985056E-07 |
Normal-vs-Age(81-100Yrs) |
3.274600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.695810E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.022160E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.291800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.457700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.751600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.535000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.389400E-01 |
Normal-vs-Grade 3 |
9.106600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.773200E-01 |
Grade 2-vs-Grade 4 |
9.389400E-01 |
Grade 3-vs-Grade 4 |
9.106600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.40170000448603E-08 |
Normal-vs-N1 |
9.976700E-03 |
N0-vs-N1 |
3.121700E-02 |
|
|